Par Drugs and Chemicals Limited

NSE:PAR.NS

95.99 (INR) • At close July 4, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 223.298213.811346.569226.056228.192239.991258.873229.347238.379229.327248.18235.065212.064169.155195.948164.834153.408162.719141.336141.336133.686133.686145.557145.557107.309107.309124.308124.308
Cost of Revenue 97.77488.085143.2674.86199.264101.517110.239116.247349.154102.592104.247108.057304.58464.91968.12861.006206.92761.47752.98452.98459.92359.92361.60361.60342.0442.0454.06754.067
Gross Profit 125.524125.726203.309151.195128.928138.474148.634113.1-110.775126.735143.933127.008-92.52104.236127.82103.828-53.519101.24288.35388.35373.76373.76383.95583.95565.26865.26870.24170.241
Gross Profit Ratio 0.5620.5880.5870.6690.5650.5770.5740.493-0.4650.5530.580.54-0.4360.6160.6520.63-0.3490.6220.6250.6250.5520.5520.5770.5770.6080.6080.5650.565
Reseach & Development Expenses 000000002.7750001.2170000.9880000.3330.333000.2720.27200
General & Administrative Expenses 0000000000000000000000000000
Selling & Marketing Expenses 0000000000000000000000000000
SG&A 19.101098.30812.61776.90894.83783.48780.0915.57513.39374.54680.54669.10258.37777.76753.70812.0210.3858.698.6910.36810.36810.210.27.9167.91610.55910.559
Other Expenses 0120.5790117.883-0.482.2910.4910.12100.3770.15897.419-125.8850.5180.2770.374-0.3460.3110000000000
Operating Expenses 19.101120.57998.308117.88376.90894.83783.48780.09-151.905101.85394.01397.419-125.88576.38195.72270.594-88.9668.43456.39656.39652.95552.95571.33571.33556.36456.36454.99954.999
Operating Income 106.4235.147105.00133.31252.0243.63765.14733.0145.34924.88250.07931.12336.45428.37332.37533.60736.33333.11931.68531.68520.82420.82412.61212.6129.7199.71915.91215.912
Operating Income Ratio 0.4770.0240.3030.1470.2280.1820.2520.1440.190.1090.2020.1320.1720.1680.1650.2040.2370.2040.2240.2240.1560.1560.0870.0870.0910.0910.1280.128
Total Other Income Expenses Net -83.6362.5779.8680.538-0.9312.0950.224-0.0360.0450.082-0.1411.0672.918-0.472-2.0050.03918.633-0.179-1.406-1.406-1.389-1.389-2.088-2.088-51.089-51.089-5.72-5.72
Income Before Tax 22.7877.724114.86933.8551.08945.73265.37132.97445.39424.96449.77930.65636.28327.38330.09333.27354.07432.62930.27930.27919.43519.43510.52410.5245.9915.99110.19210.192
Income Before Tax Ratio 0.1020.0360.3310.150.2240.1910.2530.1440.190.1090.2010.130.1710.1620.1540.2020.3520.2010.2140.2140.1450.1450.0720.0720.0560.0560.0820.082
Income Tax Expense 6.2771.94428.918.51913.89511.5116.4538.29910.9246.28312.5287.71512.0416.237.898.729.90211.7984.7254.7253.5533.5532.5812.5813.9033.9033.3543.354
Net Income 16.515.7885.95825.33137.19434.22248.91824.67534.4718.6837.25122.9424.24221.15322.20324.55344.17220.83125.55525.55515.88215.8827.9437.9432.0882.0886.8396.839
Net Income Ratio 0.0740.0270.2480.1120.1630.1430.1890.1080.1450.0810.150.0980.1140.1250.1130.1490.2880.1280.1810.1810.1190.1190.0550.0550.0190.0190.0550.055
EPS 1.340.476.992.063.022.783.982.012.81.523.031.861.971.721.823.593.392.082.081.291.290.650.650.170.171.271.27
EPS Diluted 1.340.476.992.063.022.783.982.012.81.523.031.861.971.721.823.593.392.082.081.291.290.650.650.170.171.271.27
EBITDA 24.19917.009124.24543.08460.00854.58174.11641.44254.14332.68459.20538.42345.88836.1240.72441.65363.51939.32839.04639.04621.15421.15426.08926.08918.27418.27422.54222.542
EBITDA Ratio 0.1080.080.3590.1910.2630.2270.2860.1810.2270.1430.2390.1630.2160.2140.2080.2530.4140.2420.2760.2760.1580.1580.1790.1790.170.170.1810.181